PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 70 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $315,227 | +66.8% | 11,413 | -49.1% | 0.01% | +14.3% |
| Q3 2022 | $189,000 | -18.5% | 22,421 | +128.9% | 0.01% | -36.4% |
| Q1 2022 | $232,000 | -15.0% | 9,795 | -6.9% | 0.01% | -56.0% |
| Q1 2021 | $273,000 | -25.0% | 10,522 | -41.8% | 0.02% | -35.9% |
| Q4 2020 | $364,000 | +92.6% | 18,074 | +68.8% | 0.04% | +200.0% |
| Q2 2020 | $189,000 | +30.3% | 10,707 | -47.7% | 0.01% | +18.2% |
| Q1 2020 | $145,000 | +17.9% | 20,481 | +11.8% | 0.01% | +37.5% |
| Q4 2018 | $123,000 | -59.5% | 18,317 | -38.1% | 0.01% | -65.2% |
| Q3 2018 | $304,000 | +57.5% | 29,580 | +31.4% | 0.02% | +76.9% |
| Q1 2018 | $193,000 | -45.8% | 22,506 | +31.6% | 0.01% | -66.7% |
| Q4 2017 | $356,000 | – | 17,106 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $67,646,434 | 21.00% |
| COWEN AND COMPANY, LLC | 1,657,551 | $45,781,558 | 3.80% |
| Kynam Capital Management, LP | 975,298 | $26,937,731 | 3.70% |
| BVF INC/IL | 3,775,900 | $104,290,358 | 2.91% |
| RTW INVESTMENTS, LP | 5,415,514 | $149,576,497 | 2.85% |
| Cormorant Asset Management, LP | 1,500,000 | $41,430,000 | 2.32% |
| Ghost Tree Capital, LLC | 225,000 | $6,214,500 | 2.05% |
| 683 Capital Management, LLC | 814,000 | $22,482,680 | 1.62% |
| Perceptive Advisors | 1,469,761 | $40,594,799 | 1.18% |
| Artia Global Partners LP | 112,340 | $3,102,831 | 1.07% |